Sunday, 02 October 2022

  1. Poll
  2. Industry

Poll

Industry

Is lockdown hurting india more than COVID-19?

  View poll results   More polls

Leadership

image credit- shutterstock

Driving Up Drug Discovery...

“High-speed 5G connectivity ca...

Synthetic Biology- The ticket ...

“We plan to introduce 25 new t...

“We leverage India as a market...

"We need policies for building...

TRENDING TOPICS

Ensure access to pumps and CGM

ICMR & IISc to create gold sta

First-of-its-kind comprehensiv

Alkem Labs, Stempeutics get DC





Most read

Merck opens R&D Excellence Centre i
Image Credit: PIB

Reconstituted National Medical Devi
image credit- shutterstock

Oncology, digital health startups t

C-CAMP, USAID launch respiratory su

Survey Box

Can mRNA technology prove to be beneficial for the Indian biopharma sector?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Subscribe to BioSpectrum India

Enquiry

Contact Us

MMA

Ashirwad Bungalow, First floor,
36/A/2, S.No. 270, Pallod Farms,
Near Bank of Baroda, Baner Road,
Pune, Maharashtra, India 411045

Mob : +91-9579069369

Email : communications@mmactiv.com

**Disclaimer

Visit Our Digital Magazine :

BioSpectrum Asia

NuFFooDS Spectrum

Sitemap

© 2022 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer

Web Interface Conceived and Powered By : SCI Knowledge Interlinks